Biotest AG
BIESF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $124 | $204 | $151 | $157 |
| % Growth | -39% | 35% | -3.9% | – |
| Cost of Goods Sold | $110 | $151 | $122 | $106 |
| Gross Profit | $14 | $53 | $29 | $51 |
| % Margin | 11.4% | 26% | 19.4% | 32.6% |
| R&D Expenses | $15 | $11 | $17 | $14 |
| G&A Expenses | $10 | $11 | $9 | $8 |
| SG&A Expenses | $21 | $29 | $15 | $21 |
| Sales & Mktg Exp. | $11 | $18 | $6 | $13 |
| Other Operating Expenses | $1 | -$10 | $5 | -$10 |
| Operating Expenses | $37 | $30 | $37 | $26 |
| Operating Income | -$23 | $23 | -$7 | $26 |
| % Margin | -18.5% | 11.5% | -4.8% | 16.3% |
| Other Income/Exp. Net | -$7 | -$21 | -$8 | -$8 |
| Pre-Tax Income | -$30 | $2 | -$15 | $17 |
| Tax Expense | -$9 | $6 | -$6 | $8 |
| Net Income | -$21 | -$4 | -$9 | $10 |
| % Margin | -17.2% | -1.7% | -6.2% | 6.2% |
| EPS | -0.55 | -0.094 | -0.25 | 0.24 |
| % Growth | -485.1% | 62.4% | -204.2% | – |
| EPS Diluted | -0.55 | -0.094 | -0.25 | 0.24 |
| Weighted Avg Shares Out | 39 | 37 | 37 | 40 |
| Weighted Avg Shares Out Dil | 39 | 37 | 37 | 40 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $0 | $2 | $2 |
| Interest Expense | $12 | $1 | $10 | $10 |
| Depreciation & Amortization | $8 | $8 | $8 | $9 |
| EBITDA | -$10 | $12 | $2 | $35 |
| % Margin | -7.7% | 5.8% | 1.5% | 22.2% |